4SC-203

Generic Name: 4SC-203

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₃₃H_₃₈N_₈O_₄S

CAS Number: 895533-09-2

Unique Ingredient Identifier: RFG3GJ6251

Background: 4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Single Dose Study With 4SC-203 in Healthy Volunteers

Phase 1

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: 4SC-203
Drug: Placebo

First Posted Date: 2010-01-22

Last Posted Date: 2011-01-13

Lead Sponsor: 4SC AG

Target Recruit Count: 60

Registration Number: NCT01054937

Locations: 🇩🇪
Charité Research Organisation, Berlin, Germany

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy